FIT Biotech Oy logo

FITBIO - FIT Biotech Oy Share Price

€0 0.0  0.0%

Last Trade - 22/02/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1850
Bullish
Bearish
Unlock FITBIO Revenue
Momentum
Relative Strength (%)
1m -0.62%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
0.000 0.12 0.030 0.020 0.010 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2018, FIT BiotechOy revenues was not reported. Net loss increased 33% toEUR1.8M. Higher net loss reflects Other operating expensesincrease of 39% to EUR916K (expense), Other OperatingIncome decrease of 72% to EUR97K (income),Depreciation/Amortization increase of 26% to EUR102K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

FITBIO Revenue Unlock FITBIO Revenue

Net Income

FITBIO Net Income Unlock FITBIO Revenue

Normalised EPS

FITBIO Normalised EPS Unlock FITBIO Revenue

PE Ratio Range

FITBIO PE Ratio Range Unlock FITBIO Revenue

Dividend Yield Range

FITBIO Dividend Yield Range Unlock FITBIO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
FITBIO EPS Forecasts Unlock FITBIO Revenue
Profile Summary

FIT Biotech Oy is a Finland-based biotechnology company that develops and licenses its patented Gene Transport Unit (GTU) vector technology for new-generation medical treatments. The Company’s GTU is a gene transport technology that solves challenge in the usability of gene therapy and deoxyribonucleic acid (DNA) vaccines. The Company primarily focuses on verifying the preclinical efficacy of its developed drug candidates (proof-of-concept). FIT Biotech Oy applies its GTU technology in seven drug development projects, including cancer (gene therapy), infectious diseases, such as human immunodeficiency virus (HIV) and tuberculosis, as well as animal vaccines.

Directors
Last Annual December 31st, 2017
Last Interim June 30th, 2018
Incorporated May 17, 1995
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange - Helsinki
Shares in Issue 2,413,787,043
Free Float (0.0%)
Eligible for
ISAs
SIPPs
33520
View larger map
+
Address Biokatu 12, TAMPERE, 33520, Finland
Web
Phone +358 3 31387000
Auditors PricewaterhouseCoopers Oy
FITBIO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for FITBIO
Upcoming Events for FITBIO
Frequently Asked Questions for FIT Biotech Oy
What is the FIT Biotech Oy share price?

As of 22/02/19, shares in FIT Biotech Oy are trading at €0, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the FIT Biotech Oy share price performed this year?

Shares in FIT Biotech Oy are currently trading at €0 and the price has moved by -92.31% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the FIT Biotech Oy price has moved by -93.05% over the past year.

What are the analyst and broker recommendations for FIT Biotech Oy?

There are no analysts currently covering FIT Biotech Oy.

When will FIT Biotech Oy next release its financial results?

FIT Biotech Oy is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-06-30
What is the FIT Biotech Oy dividend yield?

FIT Biotech Oy does not currently pay a dividend.

Does FIT Biotech Oy pay a dividend?

FIT Biotech Oy does not currently pay a dividend.

When does FIT Biotech Oy next pay dividends?

FIT Biotech Oy does not currently pay a dividend.

How do I buy FIT Biotech Oy shares?

To buy shares in FIT Biotech Oy you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of FIT Biotech Oy?

Shares in FIT Biotech Oy are currently trading at €0, giving the company a market capitalisation of £n/a.

Where are FIT Biotech Oy shares listed? Where are FIT Biotech Oy shares listed?

Here are the trading details for FIT Biotech Oy:

Country of listing: Finland
Exchange: HEX
Ticker Symbol: FITBIO
What kind of share is FIT Biotech Oy?

We were not able to load our ranking data for FIT Biotech Oy

Is there a FIT Biotech Oy share price forecast 2021?

We were not able to load any forecast data for FIT Biotech Oy.

How can I tell whether the FIT Biotech Oy share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like FIT Biotech Oy. Over the past six months, the relative strength of its shares against the market has been -70.04%. At the current price of €0, shares in FIT Biotech Oy are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the FIT Biotech Oy PE Ratio?

We were not able to find PE ratio data for FIT Biotech Oy.

Who are the key directors of FIT Biotech Oy?

We were unable to find the directors for FIT Biotech Oy.

Who are the major shareholders of FIT Biotech Oy?

Here are the top five shareholders of FIT Biotech Oy based on the size of their shareholding:

Similar to FITBIO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.